Central Illinois Hematology is categorized under Hematologists in Springfield, IL and active since 1986.
Central Illinois Hematology was established in 1986, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sue Coffee, Office Manager at the company’s single location by writing to 747 North Rutledge St, Springfield, Illinois IL 62702 or by phoning (217) 321-2500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Illinois Hematology |
| Contact Person: | Sue Coffee, Office Manager |
| Address: | 747 North Rutledge St, Springfield, Illinois 62702 |
| Phone Number: | (217) 321-2500 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Central Illinois Hematology was started in 1986 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Sue Coffee, Office Manager for inquiries that concern Central Illinois Hematology by calling the company number (217) 321-2500, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Illinois Hematology can be found at the coordinates 39.80927,-89.65743 as well as the street address 747 North Rutledge St in Springfield, Illinois 62702.
For its online presence, you may visit Central Illinois Hematology’s website at and engage with its social media outlets through on Twitter and on Facebook.